Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension | 54 | 2023 | 8610 | 3.740 |
Why?
|
Blood Pressure | 42 | 2023 | 8537 | 2.890 |
Why?
|
Ventricular Dysfunction, Left | 28 | 2023 | 2145 | 2.860 |
Why?
|
Cardiovascular Diseases | 61 | 2023 | 15638 | 2.580 |
Why?
|
Sex Characteristics | 10 | 2023 | 2667 | 2.440 |
Why?
|
Heart Failure | 61 | 2023 | 11859 | 2.260 |
Why?
|
Echocardiography | 42 | 2023 | 5043 | 2.210 |
Why?
|
Ventricular Function, Left | 35 | 2024 | 3941 | 2.100 |
Why?
|
Ventricular Remodeling | 24 | 2023 | 1280 | 2.000 |
Why?
|
Hypertrophy, Left Ventricular | 13 | 2022 | 857 | 1.610 |
Why?
|
Metabolome | 11 | 2017 | 1009 | 1.510 |
Why?
|
Takotsubo Cardiomyopathy | 2 | 2022 | 125 | 1.380 |
Why?
|
Atherosclerosis | 26 | 2021 | 3431 | 1.280 |
Why?
|
Heart Ventricles | 14 | 2022 | 3839 | 1.140 |
Why?
|
Coronary Vessels | 7 | 2022 | 3123 | 1.120 |
Why?
|
Eicosanoids | 5 | 2023 | 284 | 1.120 |
Why?
|
Echocardiography, Doppler | 12 | 2020 | 899 | 1.070 |
Why?
|
Myocardium | 15 | 2023 | 4789 | 1.070 |
Why?
|
Risk Factors | 112 | 2024 | 74915 | 1.020 |
Why?
|
Brachial Artery | 6 | 2017 | 374 | 1.010 |
Why?
|
Diabetes Mellitus | 19 | 2023 | 5887 | 0.980 |
Why?
|
Carotid Arteries | 7 | 2021 | 943 | 0.970 |
Why?
|
Middle Aged | 183 | 2024 | 223406 | 0.970 |
Why?
|
Heart Diseases | 9 | 2021 | 2816 | 0.970 |
Why?
|
Humans | 323 | 2024 | 768369 | 0.970 |
Why?
|
Female | 231 | 2024 | 396926 | 0.970 |
Why?
|
Male | 223 | 2023 | 364761 | 0.950 |
Why?
|
Quantitative Trait, Heritable | 3 | 2023 | 540 | 0.950 |
Why?
|
Aging | 8 | 2022 | 8762 | 0.930 |
Why?
|
Myocarditis | 2 | 2022 | 804 | 0.930 |
Why?
|
Cardiomyopathies | 7 | 2023 | 2056 | 0.920 |
Why?
|
Stroke Volume | 33 | 2024 | 5620 | 0.910 |
Why?
|
Myocardial Contraction | 6 | 2015 | 1527 | 0.890 |
Why?
|
Fetal Macrosomia | 1 | 2024 | 138 | 0.890 |
Why?
|
Carbon Monoxide | 4 | 2020 | 551 | 0.880 |
Why?
|
Longitudinal Studies | 36 | 2022 | 14766 | 0.850 |
Why?
|
Aged | 144 | 2024 | 171514 | 0.850 |
Why?
|
Hypercholesterolemia | 3 | 2018 | 1142 | 0.800 |
Why?
|
Prehypertension | 3 | 2017 | 63 | 0.800 |
Why?
|
Sex | 1 | 2022 | 53 | 0.790 |
Why?
|
Hemodynamics | 9 | 2021 | 4202 | 0.760 |
Why?
|
Obesity | 19 | 2023 | 13065 | 0.760 |
Why?
|
Health Status Disparities | 3 | 2018 | 1876 | 0.740 |
Why?
|
Vital Signs | 1 | 2022 | 144 | 0.730 |
Why?
|
Heart | 10 | 2023 | 4451 | 0.720 |
Why?
|
Electrocardiography | 11 | 2022 | 6410 | 0.710 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 406 | 0.700 |
Why?
|
Systole | 11 | 2023 | 938 | 0.700 |
Why?
|
Antibodies, Viral | 9 | 2023 | 3210 | 0.690 |
Why?
|
Diastole | 12 | 2020 | 784 | 0.690 |
Why?
|
Adult Children | 1 | 2020 | 104 | 0.690 |
Why?
|
Natriuretic Peptide, Brain | 15 | 2020 | 1751 | 0.680 |
Why?
|
Metabolomics | 8 | 2019 | 1675 | 0.680 |
Why?
|
Antibody Formation | 3 | 2023 | 1393 | 0.670 |
Why?
|
Pulmonary Edema | 3 | 2020 | 409 | 0.660 |
Why?
|
Coronary Circulation | 5 | 2020 | 1618 | 0.650 |
Why?
|
Sex Factors | 21 | 2022 | 10647 | 0.640 |
Why?
|
Microcirculation | 2 | 2020 | 1283 | 0.630 |
Why?
|
Adult | 96 | 2024 | 223528 | 0.620 |
Why?
|
Adipokines | 2 | 2018 | 309 | 0.610 |
Why?
|
Coronary Disease | 7 | 2019 | 5926 | 0.610 |
Why?
|
Antihypertensive Agents | 9 | 2023 | 2028 | 0.600 |
Why?
|
Los Angeles | 4 | 2022 | 245 | 0.590 |
Why?
|
Electronic Health Records | 5 | 2024 | 4877 | 0.590 |
Why?
|
Prognosis | 46 | 2023 | 30031 | 0.590 |
Why?
|
Aged, 80 and over | 53 | 2024 | 59679 | 0.580 |
Why?
|
Stroke | 12 | 2023 | 9790 | 0.580 |
Why?
|
Hypertension, Pulmonary | 3 | 2023 | 1605 | 0.560 |
Why?
|
Vascular Diseases | 3 | 2022 | 1162 | 0.550 |
Why?
|
Coronary Artery Disease | 13 | 2022 | 6549 | 0.550 |
Why?
|
Myocardial Infarction | 14 | 2023 | 11515 | 0.550 |
Why?
|
American Heart Association | 5 | 2022 | 1049 | 0.540 |
Why?
|
Atrial Function, Left | 4 | 2019 | 188 | 0.530 |
Why?
|
Pacemaker, Artificial | 3 | 2011 | 828 | 0.530 |
Why?
|
Natriuretic Peptides | 3 | 2011 | 156 | 0.520 |
Why?
|
Risk Assessment | 36 | 2022 | 24310 | 0.510 |
Why?
|
Cohort Studies | 37 | 2024 | 41782 | 0.510 |
Why?
|
Vaccination | 12 | 2023 | 3433 | 0.510 |
Why?
|
Multivariate Analysis | 19 | 2021 | 12096 | 0.500 |
Why?
|
Longevity | 3 | 2016 | 1078 | 0.500 |
Why?
|
Isocitrates | 1 | 2015 | 23 | 0.500 |
Why?
|
Taurocholic Acid | 1 | 2015 | 44 | 0.500 |
Why?
|
Incidence | 26 | 2021 | 21552 | 0.490 |
Why?
|
Massachusetts | 18 | 2019 | 8905 | 0.480 |
Why?
|
Diabetes Complications | 3 | 2020 | 1322 | 0.480 |
Why?
|
Age Factors | 18 | 2021 | 18477 | 0.480 |
Why?
|
Predictive Value of Tests | 28 | 2022 | 15459 | 0.470 |
Why?
|
Age of Onset | 7 | 2021 | 3342 | 0.470 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 1259 | 0.470 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2015 | 167 | 0.470 |
Why?
|
Health Personnel | 5 | 2022 | 3384 | 0.450 |
Why?
|
Smoking | 8 | 2022 | 9099 | 0.450 |
Why?
|
Proportional Hazards Models | 18 | 2022 | 12561 | 0.450 |
Why?
|
Vaccines | 1 | 2022 | 845 | 0.450 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2013 | 69 | 0.440 |
Why?
|
Myocardial Ischemia | 6 | 2022 | 2139 | 0.430 |
Why?
|
Hospitalization | 6 | 2022 | 10845 | 0.430 |
Why?
|
Algorithms | 7 | 2024 | 14157 | 0.430 |
Why?
|
Peptide Fragments | 10 | 2020 | 5151 | 0.430 |
Why?
|
Inflammatory Bowel Diseases | 6 | 2023 | 2444 | 0.420 |
Why?
|
United States | 49 | 2023 | 73120 | 0.410 |
Why?
|
Brain Ischemia | 3 | 2023 | 3038 | 0.410 |
Why?
|
Cardiomyopathy, Hypertrophic | 4 | 2022 | 1333 | 0.410 |
Why?
|
Cardiovascular System | 3 | 2016 | 838 | 0.400 |
Why?
|
Family Health | 1 | 2017 | 1256 | 0.400 |
Why?
|
Artificial Intelligence | 4 | 2023 | 2659 | 0.400 |
Why?
|
Leisure Activities | 2 | 2016 | 310 | 0.400 |
Why?
|
Phenotype | 14 | 2024 | 16712 | 0.380 |
Why?
|
Exhalation | 2 | 2020 | 185 | 0.380 |
Why?
|
Adiposity | 5 | 2020 | 1888 | 0.370 |
Why?
|
Prospective Studies | 46 | 2023 | 54913 | 0.360 |
Why?
|
Pericytes | 1 | 2013 | 299 | 0.350 |
Why?
|
Heart Atria | 6 | 2022 | 1361 | 0.350 |
Why?
|
Pyrroles | 2 | 2013 | 1127 | 0.340 |
Why?
|
Ultrasonography | 10 | 2020 | 5994 | 0.330 |
Why?
|
Amino Acids, Branched-Chain | 4 | 2020 | 269 | 0.330 |
Why?
|
Growth Differentiation Factor 15 | 5 | 2014 | 199 | 0.330 |
Why?
|
Critical Care | 3 | 2023 | 2717 | 0.330 |
Why?
|
Indoles | 3 | 2024 | 1834 | 0.330 |
Why?
|
Body Mass Index | 16 | 2024 | 13030 | 0.320 |
Why?
|
Heart Block | 1 | 2011 | 390 | 0.320 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2021 | 3407 | 0.320 |
Why?
|
Image Processing, Computer-Assisted | 7 | 2021 | 9066 | 0.320 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1244 | 0.310 |
Why?
|
Microvessels | 1 | 2013 | 586 | 0.310 |
Why?
|
Workflow | 4 | 2023 | 861 | 0.310 |
Why?
|
Ovarian Neoplasms | 5 | 2024 | 4906 | 0.310 |
Why?
|
Metabolic Networks and Pathways | 2 | 2016 | 797 | 0.310 |
Why?
|
Atrial Fibrillation | 9 | 2022 | 5162 | 0.310 |
Why?
|
Elasticity Imaging Techniques | 1 | 2013 | 391 | 0.310 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2009 | 56 | 0.310 |
Why?
|
Bundle-Branch Block | 1 | 2010 | 278 | 0.310 |
Why?
|
Receptors, Cell Surface | 7 | 2014 | 2818 | 0.300 |
Why?
|
Linear Models | 10 | 2021 | 5880 | 0.300 |
Why?
|
Prevalence | 19 | 2019 | 15879 | 0.300 |
Why?
|
Lipids | 6 | 2022 | 3346 | 0.300 |
Why?
|
Obesity, Abdominal | 1 | 2011 | 375 | 0.300 |
Why?
|
Research Design | 3 | 2022 | 6217 | 0.300 |
Why?
|
Outpatients | 2 | 2018 | 1607 | 0.300 |
Why?
|
Case-Control Studies | 11 | 2022 | 22286 | 0.300 |
Why?
|
Troponin T | 3 | 2019 | 787 | 0.290 |
Why?
|
Abdominal Fat | 1 | 2009 | 221 | 0.290 |
Why?
|
Pulsatile Flow | 5 | 2016 | 320 | 0.290 |
Why?
|
Aorta, Abdominal | 1 | 2010 | 627 | 0.290 |
Why?
|
Atrioventricular Block | 1 | 2009 | 141 | 0.280 |
Why?
|
Blood Glucose | 8 | 2021 | 6429 | 0.280 |
Why?
|
Albuminuria | 4 | 2020 | 658 | 0.280 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2022 | 16023 | 0.280 |
Why?
|
Bone Marrow Cells | 2 | 2011 | 2415 | 0.280 |
Why?
|
Health Surveys | 1 | 2017 | 4056 | 0.280 |
Why?
|
Vitamin D Deficiency | 3 | 2014 | 1389 | 0.280 |
Why?
|
Retrospective Studies | 26 | 2024 | 81835 | 0.270 |
Why?
|
Immunoglobulin G | 7 | 2023 | 4570 | 0.270 |
Why?
|
Insulin Resistance | 9 | 2021 | 3974 | 0.270 |
Why?
|
Calcinosis | 2 | 2018 | 1484 | 0.270 |
Why?
|
Genome-Wide Association Study | 12 | 2024 | 12771 | 0.270 |
Why?
|
Enoxaparin | 1 | 2009 | 391 | 0.270 |
Why?
|
Time Factors | 23 | 2021 | 40271 | 0.270 |
Why?
|
Prosthesis Implantation | 1 | 2011 | 595 | 0.270 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2010 | 881 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2022 | 12242 | 0.260 |
Why?
|
Cholesterol | 4 | 2021 | 2910 | 0.260 |
Why?
|
Cross-Sectional Studies | 21 | 2021 | 26348 | 0.260 |
Why?
|
Coronary Thrombosis | 1 | 2009 | 440 | 0.260 |
Why?
|
Peripheral Arterial Disease | 2 | 2022 | 1299 | 0.260 |
Why?
|
Manometry | 4 | 2019 | 459 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3116 | 0.250 |
Why?
|
Movement | 1 | 2013 | 1489 | 0.250 |
Why?
|
Taiwan | 2 | 2024 | 528 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.250 |
Why?
|
Health Services Accessibility | 2 | 2022 | 5508 | 0.250 |
Why?
|
Troponin I | 6 | 2020 | 662 | 0.250 |
Why?
|
Isoxazoles | 2 | 2024 | 233 | 0.240 |
Why?
|
Blood Pressure Determination | 2 | 2020 | 646 | 0.240 |
Why?
|
Chromatography, Liquid | 3 | 2019 | 998 | 0.240 |
Why?
|
Asymptomatic Diseases | 3 | 2018 | 591 | 0.240 |
Why?
|
Follow-Up Studies | 24 | 2020 | 39429 | 0.240 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2022 | 2291 | 0.240 |
Why?
|
Ventricular Function | 2 | 2021 | 406 | 0.240 |
Why?
|
Blood | 2 | 2022 | 597 | 0.240 |
Why?
|
Genetic Loci | 4 | 2019 | 2630 | 0.230 |
Why?
|
Disease Progression | 9 | 2023 | 13643 | 0.230 |
Why?
|
Prediabetic State | 3 | 2015 | 548 | 0.230 |
Why?
|
Long QT Syndrome | 2 | 2020 | 472 | 0.230 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1369 | 0.230 |
Why?
|
Dihydrotestosterone | 2 | 2023 | 195 | 0.230 |
Why?
|
Phthalazines | 2 | 2024 | 396 | 0.230 |
Why?
|
Young Adult | 16 | 2021 | 60038 | 0.230 |
Why?
|
Reproducibility of Results | 13 | 2023 | 20232 | 0.220 |
Why?
|
Diagnostic Imaging | 2 | 2017 | 3543 | 0.220 |
Why?
|
Lung | 4 | 2020 | 10090 | 0.220 |
Why?
|
Mass Spectrometry | 4 | 2023 | 2204 | 0.220 |
Why?
|
Heart Rate | 6 | 2020 | 4218 | 0.220 |
Why?
|
Ankle Brachial Index | 4 | 2022 | 163 | 0.220 |
Why?
|
Magnetic Resonance Imaging, Cine | 3 | 2023 | 1092 | 0.220 |
Why?
|
Dementia | 2 | 2022 | 2724 | 0.210 |
Why?
|
Cardiomegaly | 2 | 2018 | 592 | 0.210 |
Why?
|
Angiogenesis Inhibitors | 1 | 2013 | 2062 | 0.210 |
Why?
|
Odds Ratio | 7 | 2022 | 9687 | 0.210 |
Why?
|
Adipose Tissue | 2 | 2018 | 3335 | 0.210 |
Why?
|
Pandemics | 9 | 2023 | 8751 | 0.210 |
Why?
|
Immunization, Secondary | 2 | 2022 | 371 | 0.210 |
Why?
|
Motor Activity | 1 | 2012 | 2722 | 0.210 |
Why?
|
Genetic Variation | 5 | 2023 | 6607 | 0.200 |
Why?
|
Oxylipins | 2 | 2020 | 54 | 0.200 |
Why?
|
Heart Function Tests | 1 | 2023 | 318 | 0.200 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 622 | 0.200 |
Why?
|
Proteomics | 4 | 2023 | 3901 | 0.190 |
Why?
|
Retinal Vein | 1 | 2021 | 47 | 0.190 |
Why?
|
Barbering | 1 | 2021 | 12 | 0.190 |
Why?
|
Triglycerides | 6 | 2021 | 2465 | 0.190 |
Why?
|
Heparin | 1 | 2009 | 1636 | 0.190 |
Why?
|
Exercise | 7 | 2022 | 5940 | 0.190 |
Why?
|
Radiopharmaceuticals | 5 | 2022 | 2731 | 0.190 |
Why?
|
Community Pharmacy Services | 1 | 2021 | 52 | 0.190 |
Why?
|
Awareness | 1 | 2005 | 654 | 0.190 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2021 | 94 | 0.180 |
Why?
|
Cause of Death | 4 | 2017 | 3727 | 0.180 |
Why?
|
Aortic Diseases | 2 | 2020 | 742 | 0.180 |
Why?
|
Pyrazines | 2 | 2024 | 1206 | 0.180 |
Why?
|
C-Reactive Protein | 8 | 2022 | 3854 | 0.180 |
Why?
|
Stem Cells | 2 | 2011 | 3538 | 0.180 |
Why?
|
Heart-Assist Devices | 2 | 2022 | 1292 | 0.180 |
Why?
|
Severity of Illness Index | 9 | 2021 | 15965 | 0.180 |
Why?
|
Deoxycytidine | 2 | 2024 | 888 | 0.180 |
Why?
|
Fluorine Radioisotopes | 2 | 2021 | 425 | 0.180 |
Why?
|
Carotid Artery Diseases | 3 | 2018 | 879 | 0.180 |
Why?
|
Immunity, Humoral | 2 | 2022 | 612 | 0.180 |
Why?
|
Neoplasms | 6 | 2021 | 22389 | 0.180 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2022 | 241 | 0.170 |
Why?
|
Blood Flow Velocity | 4 | 2020 | 1377 | 0.170 |
Why?
|
Patient Compliance | 2 | 2021 | 2696 | 0.170 |
Why?
|
Immunoglobulin M | 2 | 2023 | 1528 | 0.170 |
Why?
|
Telemedicine | 3 | 2021 | 3104 | 0.160 |
Why?
|
Vitamin D | 2 | 2011 | 3311 | 0.160 |
Why?
|
Stress, Mechanical | 2 | 2015 | 1680 | 0.160 |
Why?
|
Glucose Tolerance Test | 3 | 2018 | 1181 | 0.160 |
Why?
|
Tandem Mass Spectrometry | 4 | 2019 | 1197 | 0.160 |
Why?
|
Vasodilation | 2 | 2015 | 968 | 0.160 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2022 | 417 | 0.160 |
Why?
|
Lactobacillus | 1 | 2020 | 212 | 0.160 |
Why?
|
Azithromycin | 1 | 2020 | 200 | 0.160 |
Why?
|
Ethylene Glycols | 1 | 2020 | 198 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 9 | 2021 | 18047 | 0.160 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2017 | 353 | 0.160 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2018 | 108 | 0.150 |
Why?
|
Scleroderma, Systemic | 1 | 2022 | 349 | 0.150 |
Why?
|
Medical History Taking | 1 | 2022 | 776 | 0.150 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2021 | 263 | 0.150 |
Why?
|
Receptors, Androgen | 2 | 2023 | 1084 | 0.150 |
Why?
|
Atrial Function, Right | 1 | 2018 | 32 | 0.150 |
Why?
|
Risk Reduction Behavior | 3 | 2020 | 1120 | 0.150 |
Why?
|
Preventive Health Services | 2 | 2021 | 568 | 0.150 |
Why?
|
Sphingolipids | 1 | 2020 | 178 | 0.150 |
Why?
|
Parents | 3 | 2017 | 3596 | 0.150 |
Why?
|
Ceramides | 1 | 2019 | 203 | 0.150 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2020 | 154 | 0.150 |
Why?
|
Diphtheria Antitoxin | 1 | 2017 | 7 | 0.150 |
Why?
|
Dyslipidemias | 3 | 2016 | 874 | 0.150 |
Why?
|
BCG Vaccine | 1 | 2021 | 383 | 0.150 |
Why?
|
Biological Factors | 1 | 2019 | 158 | 0.150 |
Why?
|
Inhalation Exposure | 1 | 2020 | 433 | 0.150 |
Why?
|
Diphtheria | 1 | 2017 | 32 | 0.150 |
Why?
|
Quinazolines | 1 | 2024 | 1376 | 0.140 |
Why?
|
Tibial Arteries | 1 | 2017 | 60 | 0.140 |
Why?
|
Renal Insufficiency | 1 | 2023 | 809 | 0.140 |
Why?
|
Aorta | 3 | 2014 | 2046 | 0.140 |
Why?
|
Intestinal Absorption | 1 | 2018 | 400 | 0.140 |
Why?
|
Cardiac Volume | 1 | 2018 | 197 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 835 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2021 | 560 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11844 | 0.140 |
Why?
|
Heart Transplantation | 2 | 2022 | 3291 | 0.140 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 429 | 0.140 |
Why?
|
Neprilysin | 1 | 2020 | 487 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2021 | 992 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2022 | 520 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1085 | 0.140 |
Why?
|
Forecasting | 2 | 2017 | 2950 | 0.140 |
Why?
|
Sodium, Dietary | 1 | 2020 | 427 | 0.140 |
Why?
|
Mouth Neoplasms | 1 | 2022 | 598 | 0.140 |
Why?
|
Patient Care Planning | 2 | 2020 | 904 | 0.140 |
Why?
|
Coronary Occlusion | 1 | 2019 | 307 | 0.130 |
Why?
|
Cardiology | 2 | 2021 | 1701 | 0.130 |
Why?
|
Food | 1 | 2021 | 770 | 0.130 |
Why?
|
Amyloid | 1 | 2021 | 852 | 0.130 |
Why?
|
Breath Tests | 2 | 2015 | 300 | 0.130 |
Why?
|
Plasma | 2 | 2017 | 586 | 0.130 |
Why?
|
Protease Inhibitors | 1 | 2020 | 753 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2021 | 865 | 0.130 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2017 | 355 | 0.130 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 427 | 0.130 |
Why?
|
Seasons | 1 | 2022 | 1526 | 0.130 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 420 | 0.130 |
Why?
|
Carcinoma, Lobular | 1 | 2020 | 480 | 0.130 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 840 | 0.130 |
Why?
|
Health Status | 5 | 2020 | 4096 | 0.120 |
Why?
|
Family Characteristics | 1 | 2020 | 1001 | 0.120 |
Why?
|
Diabetic Angiopathies | 1 | 2020 | 806 | 0.120 |
Why?
|
Anticoagulants | 2 | 2022 | 4835 | 0.120 |
Why?
|
Choice Behavior | 1 | 2021 | 846 | 0.120 |
Why?
|
Waist Circumference | 3 | 2016 | 935 | 0.120 |
Why?
|
Waiting Lists | 1 | 2020 | 778 | 0.120 |
Why?
|
Automation | 1 | 2017 | 588 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2048 | 0.120 |
Why?
|
Cholesterol, HDL | 4 | 2020 | 1820 | 0.120 |
Why?
|
Anus Neoplasms | 2 | 2009 | 338 | 0.120 |
Why?
|
Low Back Pain | 2 | 2013 | 989 | 0.120 |
Why?
|
Hyperemia | 1 | 2016 | 225 | 0.120 |
Why?
|
Aniline Compounds | 1 | 2020 | 1094 | 0.120 |
Why?
|
DNA Replication | 1 | 2021 | 1428 | 0.120 |
Why?
|
Memory Disorders | 1 | 2021 | 1204 | 0.120 |
Why?
|
Amyloidosis | 1 | 2022 | 879 | 0.120 |
Why?
|
Geriatric Assessment | 3 | 2018 | 1422 | 0.110 |
Why?
|
Ischemic Attack, Transient | 2 | 2019 | 879 | 0.110 |
Why?
|
Logistic Models | 6 | 2021 | 13323 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 8 | 2020 | 20763 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5709 | 0.110 |
Why?
|
Breast Neoplasms | 6 | 2023 | 21157 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 1066 | 0.110 |
Why?
|
Galectin 3 | 1 | 2016 | 240 | 0.110 |
Why?
|
Tetrazoles | 1 | 2020 | 922 | 0.110 |
Why?
|
Mutation | 3 | 2021 | 30235 | 0.110 |
Why?
|
Heart Massage | 1 | 2013 | 32 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1244 | 0.110 |
Why?
|
Kidney Function Tests | 4 | 2013 | 681 | 0.110 |
Why?
|
2-Aminoadipic Acid | 1 | 2013 | 32 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 747 | 0.110 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2017 | 614 | 0.110 |
Why?
|
Doxorubicin | 1 | 2020 | 2229 | 0.110 |
Why?
|
Dietary Carbohydrates | 1 | 2018 | 896 | 0.110 |
Why?
|
Piperazines | 1 | 2024 | 2546 | 0.110 |
Why?
|
Liver Diseases | 1 | 2022 | 1307 | 0.110 |
Why?
|
Carbonated Beverages | 1 | 2014 | 210 | 0.110 |
Why?
|
Pilot Projects | 4 | 2021 | 8730 | 0.110 |
Why?
|
Vascular Resistance | 1 | 2016 | 941 | 0.110 |
Why?
|
Observer Variation | 3 | 2015 | 2622 | 0.110 |
Why?
|
Animals | 16 | 2021 | 169424 | 0.110 |
Why?
|
Ambulatory Care | 2 | 2021 | 2780 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2022 | 1257 | 0.110 |
Why?
|
Heme | 1 | 2015 | 316 | 0.110 |
Why?
|
Carcinoma in Situ | 2 | 2009 | 791 | 0.110 |
Why?
|
Arteries | 2 | 2015 | 1126 | 0.100 |
Why?
|
Cerebral Infarction | 2 | 2015 | 983 | 0.100 |
Why?
|
Biological Specimen Banks | 1 | 2018 | 783 | 0.100 |
Why?
|
Antigens, CD34 | 2 | 2013 | 656 | 0.100 |
Why?
|
Aortic Valve Stenosis | 2 | 2018 | 2031 | 0.100 |
Why?
|
Bayes Theorem | 1 | 2021 | 2359 | 0.100 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1092 | 0.100 |
Why?
|
Elastic Modulus | 1 | 2013 | 211 | 0.100 |
Why?
|
Signal Transduction | 2 | 2015 | 23639 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 22365 | 0.100 |
Why?
|
Cell-Derived Microparticles | 1 | 2014 | 161 | 0.100 |
Why?
|
Comorbidity | 4 | 2020 | 10601 | 0.100 |
Why?
|
Sex Distribution | 4 | 2015 | 2286 | 0.100 |
Why?
|
Heart Injuries | 1 | 2014 | 207 | 0.100 |
Why?
|
Life Style | 3 | 2020 | 3929 | 0.100 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 457 | 0.100 |
Why?
|
Electric Impedance | 1 | 2017 | 796 | 0.100 |
Why?
|
Vasoconstriction | 1 | 2015 | 594 | 0.100 |
Why?
|
Executive Function | 1 | 2021 | 1402 | 0.100 |
Why?
|
Software | 3 | 2021 | 4465 | 0.100 |
Why?
|
Elasticity | 2 | 2011 | 658 | 0.100 |
Why?
|
Pyridazines | 1 | 2013 | 204 | 0.100 |
Why?
|
Platelet Aggregation | 1 | 2015 | 772 | 0.100 |
Why?
|
Periodicals as Topic | 1 | 2023 | 1468 | 0.100 |
Why?
|
Primary Prevention | 1 | 2019 | 1189 | 0.100 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2023 | 1482 | 0.100 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2013 | 430 | 0.090 |
Why?
|
Estrogens | 2 | 2016 | 1531 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2024 | 5342 | 0.090 |
Why?
|
Antibodies, Bacterial | 1 | 2017 | 1480 | 0.090 |
Why?
|
Reference Values | 3 | 2013 | 4941 | 0.090 |
Why?
|
Colony-Forming Units Assay | 1 | 2011 | 352 | 0.090 |
Why?
|
Treatment Outcome | 12 | 2022 | 65408 | 0.090 |
Why?
|
Lumbosacral Region | 1 | 2013 | 294 | 0.090 |
Why?
|
Age Distribution | 2 | 2009 | 2881 | 0.090 |
Why?
|
Lung Diseases | 1 | 2021 | 1926 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2022 | 5371 | 0.090 |
Why?
|
Knee | 1 | 2013 | 279 | 0.090 |
Why?
|
Joints | 1 | 2013 | 324 | 0.090 |
Why?
|
Homosexuality | 2 | 2009 | 268 | 0.090 |
Why?
|
Benzenesulfonates | 1 | 2011 | 166 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2005 | 4049 | 0.090 |
Why?
|
Thoracic Neoplasms | 1 | 2013 | 270 | 0.090 |
Why?
|
Spinal Cord Injuries | 1 | 2018 | 928 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 11 | 2021 | 36840 | 0.090 |
Why?
|
Aortic Valve | 2 | 2018 | 1967 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2016 | 645 | 0.090 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2019 | 1543 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2021 | 1818 | 0.090 |
Why?
|
Anthracyclines | 1 | 2012 | 286 | 0.090 |
Why?
|
Heart Defects, Congenital | 2 | 2018 | 4713 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1943 | 0.090 |
Why?
|
Mice | 11 | 2021 | 82051 | 0.090 |
Why?
|
Decision Support Systems, Clinical | 1 | 2019 | 1176 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1898 | 0.090 |
Why?
|
Data Collection | 2 | 2010 | 3329 | 0.080 |
Why?
|
Antineoplastic Agents | 4 | 2021 | 13709 | 0.080 |
Why?
|
Sarcomeres | 1 | 2012 | 378 | 0.080 |
Why?
|
Arterial Occlusive Diseases | 1 | 2014 | 751 | 0.080 |
Why?
|
Pedigree | 1 | 2017 | 4545 | 0.080 |
Why?
|
Cholecalciferol | 1 | 2014 | 557 | 0.080 |
Why?
|
Nucleotides | 1 | 2012 | 455 | 0.080 |
Why?
|
Mortality | 2 | 2018 | 2917 | 0.080 |
Why?
|
Finland | 2 | 2021 | 609 | 0.080 |
Why?
|
Fontan Procedure | 1 | 2016 | 805 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2020 | 2664 | 0.080 |
Why?
|
Ultrasonography, Doppler | 1 | 2011 | 463 | 0.080 |
Why?
|
ROC Curve | 2 | 2021 | 3623 | 0.080 |
Why?
|
Anal Canal | 2 | 2009 | 376 | 0.080 |
Why?
|
Cardiac Imaging Techniques | 1 | 2012 | 281 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3253 | 0.080 |
Why?
|
Child | 5 | 2020 | 80856 | 0.080 |
Why?
|
Liver Neoplasms | 2 | 2019 | 4362 | 0.080 |
Why?
|
Glutamine | 1 | 2012 | 578 | 0.080 |
Why?
|
Ventricular Dysfunction | 1 | 2009 | 144 | 0.080 |
Why?
|
Stress, Physiological | 2 | 2013 | 1409 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 548 | 0.080 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2013 | 687 | 0.080 |
Why?
|
Cholesterol, LDL | 3 | 2022 | 2396 | 0.080 |
Why?
|
Graft Rejection | 1 | 2022 | 4505 | 0.080 |
Why?
|
Heart Valve Diseases | 1 | 2016 | 1033 | 0.080 |
Why?
|
Interleukins | 1 | 2013 | 791 | 0.080 |
Why?
|
Body Weight | 2 | 2016 | 4630 | 0.080 |
Why?
|
Electromyography | 1 | 2013 | 1399 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3906 | 0.080 |
Why?
|
Adolescent | 5 | 2020 | 89163 | 0.080 |
Why?
|
Partial Thromboplastin Time | 1 | 2009 | 204 | 0.080 |
Why?
|
Diet | 3 | 2022 | 8098 | 0.070 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2018 | 1252 | 0.070 |
Why?
|
Survival Rate | 5 | 2020 | 12875 | 0.070 |
Why?
|
Caregivers | 1 | 2020 | 2302 | 0.070 |
Why?
|
Pregnancy | 3 | 2024 | 30179 | 0.070 |
Why?
|
Menopause | 1 | 2016 | 1650 | 0.070 |
Why?
|
Iohexol | 1 | 2008 | 205 | 0.070 |
Why?
|
Iron | 1 | 2016 | 1813 | 0.070 |
Why?
|
Immunoassay | 1 | 2011 | 746 | 0.070 |
Why?
|
Patient Discharge | 1 | 2021 | 3471 | 0.070 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1547 | 0.070 |
Why?
|
Child, Preschool | 3 | 2020 | 42620 | 0.070 |
Why?
|
Imidazoles | 1 | 2013 | 1174 | 0.070 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2915 | 0.070 |
Why?
|
Skull Fractures | 1 | 2009 | 203 | 0.070 |
Why?
|
Metagenome | 2 | 2022 | 465 | 0.070 |
Why?
|
Communication | 1 | 2021 | 3910 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10269 | 0.070 |
Why?
|
Population Surveillance | 1 | 2017 | 2601 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2013 | 2433 | 0.070 |
Why?
|
Coronary Stenosis | 2 | 2019 | 803 | 0.070 |
Why?
|
Angiography | 1 | 2012 | 1597 | 0.070 |
Why?
|
Psychometrics | 3 | 2022 | 3072 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 10358 | 0.070 |
Why?
|
Antioxidants | 1 | 2015 | 1678 | 0.070 |
Why?
|
Ischemia | 3 | 2020 | 1900 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3237 | 0.070 |
Why?
|
Hypopituitarism | 1 | 2009 | 251 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2012 | 844 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2013 | 4984 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2021 | 3984 | 0.070 |
Why?
|
Cytological Techniques | 1 | 2008 | 218 | 0.070 |
Why?
|
Papillomavirus Infections | 2 | 2009 | 1637 | 0.070 |
Why?
|
Cognition | 2 | 2021 | 7062 | 0.070 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2021 | 325 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1107 | 0.070 |
Why?
|
Lipoproteins, LDL | 2 | 2020 | 644 | 0.070 |
Why?
|
Preoperative Care | 2 | 2013 | 2257 | 0.070 |
Why?
|
Family | 1 | 2017 | 3208 | 0.070 |
Why?
|
Radionuclide Ventriculography | 1 | 2005 | 40 | 0.070 |
Why?
|
Ventricular Function, Right | 3 | 2016 | 629 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1892 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4083 | 0.070 |
Why?
|
Intra-Abdominal Fat | 1 | 2011 | 623 | 0.070 |
Why?
|
Range of Motion, Articular | 1 | 2013 | 1599 | 0.070 |
Why?
|
Morbidity | 3 | 2017 | 1760 | 0.060 |
Why?
|
Diet Surveys | 2 | 2021 | 1161 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2013 | 14725 | 0.060 |
Why?
|
Mediastinal Neoplasms | 1 | 2009 | 403 | 0.060 |
Why?
|
Amino Acids | 1 | 2012 | 1713 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3463 | 0.060 |
Why?
|
Drug Discovery | 1 | 2013 | 1062 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9425 | 0.060 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2013 | 997 | 0.060 |
Why?
|
Radiation Injuries | 1 | 2013 | 1205 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2009 | 887 | 0.060 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 1226 | 0.060 |
Why?
|
Glucose Intolerance | 1 | 2009 | 579 | 0.060 |
Why?
|
Databases, Factual | 1 | 2021 | 8081 | 0.060 |
Why?
|
Gene Expression | 2 | 2015 | 7605 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 559 | 0.060 |
Why?
|
Pulmonary Artery | 1 | 2014 | 1949 | 0.060 |
Why?
|
Leukocytes | 1 | 2013 | 2030 | 0.060 |
Why?
|
Endothelial Cells | 3 | 2014 | 3586 | 0.060 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 3438 | 0.060 |
Why?
|
Heart Neoplasms | 1 | 2008 | 374 | 0.060 |
Why?
|
Up-Regulation | 3 | 2019 | 4132 | 0.060 |
Why?
|
Mendelian Randomization Analysis | 2 | 2022 | 1036 | 0.060 |
Why?
|
Flow Cytometry | 2 | 2013 | 5893 | 0.060 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7955 | 0.060 |
Why?
|
3-Iodobenzylguanidine | 1 | 2005 | 115 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3793 | 0.060 |
Why?
|
Insulin | 3 | 2013 | 6606 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2006 | 489 | 0.060 |
Why?
|
Survival Analysis | 2 | 2015 | 10127 | 0.060 |
Why?
|
Knowledge Bases | 1 | 2024 | 97 | 0.060 |
Why?
|
Specimen Handling | 1 | 2008 | 709 | 0.060 |
Why?
|
Exercise Test | 2 | 2011 | 2186 | 0.060 |
Why?
|
Betula | 1 | 2023 | 7 | 0.050 |
Why?
|
Risk | 2 | 2013 | 9642 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2013 | 2058 | 0.050 |
Why?
|
Femoral Artery | 2 | 2019 | 829 | 0.050 |
Why?
|
Organ Size | 2 | 2020 | 2268 | 0.050 |
Why?
|
Blood Coagulation | 1 | 2009 | 1163 | 0.050 |
Why?
|
Papillomaviridae | 1 | 2009 | 1135 | 0.050 |
Why?
|
Contrast Media | 2 | 2022 | 5337 | 0.050 |
Why?
|
Morganella | 1 | 2022 | 1 | 0.050 |
Why?
|
Aminoglycosides | 1 | 2003 | 161 | 0.050 |
Why?
|
Resistin | 1 | 2022 | 172 | 0.050 |
Why?
|
Blood-Brain Barrier | 1 | 2008 | 1034 | 0.050 |
Why?
|
Growth Differentiation Factors | 1 | 2022 | 100 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4426 | 0.050 |
Why?
|
Alcohol Drinking | 1 | 2015 | 4052 | 0.050 |
Why?
|
Lactase | 1 | 2022 | 72 | 0.050 |
Why?
|
Coronary Angiography | 3 | 2022 | 4526 | 0.050 |
Why?
|
Bifidobacterium | 1 | 2022 | 99 | 0.050 |
Why?
|
Mediator Complex | 1 | 2022 | 106 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2012 | 1569 | 0.050 |
Why?
|
Positron-Emission Tomography | 3 | 2023 | 6657 | 0.050 |
Why?
|
Pyrimidines | 1 | 2013 | 3050 | 0.050 |
Why?
|
Bacteria | 2 | 2023 | 2226 | 0.050 |
Why?
|
Iodine Radioisotopes | 1 | 2005 | 1035 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 102 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3246 | 0.050 |
Why?
|
Cytarabine | 1 | 2003 | 697 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 134 | 0.050 |
Why?
|
Thrombosis | 1 | 2015 | 2954 | 0.050 |
Why?
|
Convalescence | 1 | 2021 | 109 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2007 | 1724 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2489 | 0.040 |
Why?
|
Enterococcus faecalis | 1 | 2022 | 245 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 3520 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 1142 | 0.040 |
Why?
|
Meningococcal Vaccines | 1 | 2021 | 96 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2022 | 292 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3408 | 0.040 |
Why?
|
Inflammation | 3 | 2020 | 10863 | 0.040 |
Why?
|
Translations | 1 | 2020 | 82 | 0.040 |
Why?
|
Goals | 1 | 2005 | 715 | 0.040 |
Why?
|
Genome, Human | 1 | 2013 | 4454 | 0.040 |
Why?
|
Apolipoprotein B-100 | 1 | 2020 | 157 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 13025 | 0.040 |
Why?
|
Leukemia, Myeloid | 1 | 2003 | 693 | 0.040 |
Why?
|
Europe | 2 | 2021 | 3439 | 0.040 |
Why?
|
Lipoproteins, VLDL | 1 | 2020 | 201 | 0.040 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2020 | 353 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2228 | 0.040 |
Why?
|
Authorship | 1 | 2023 | 287 | 0.040 |
Why?
|
Pyridines | 1 | 2011 | 2888 | 0.040 |
Why?
|
Peptides | 2 | 2022 | 4368 | 0.040 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2021 | 219 | 0.040 |
Why?
|
Immunity, Innate | 2 | 2022 | 3076 | 0.040 |
Why?
|
Peroxidase | 1 | 2022 | 610 | 0.040 |
Why?
|
ABO Blood-Group System | 1 | 2022 | 381 | 0.040 |
Why?
|
Videoconferencing | 1 | 2021 | 207 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2010 | 3145 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2023 | 1585 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2015 | 10490 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2020 | 305 | 0.040 |
Why?
|
Live Birth | 1 | 2023 | 516 | 0.040 |
Why?
|
Psychology | 1 | 2021 | 356 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2005 | 2932 | 0.040 |
Why?
|
Leucine | 1 | 2020 | 549 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2021 | 1063 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2010 | 2901 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2023 | 1051 | 0.040 |
Why?
|
Apoptosis | 1 | 2015 | 9526 | 0.040 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2021 | 423 | 0.040 |
Why?
|
Immunization Programs | 1 | 2021 | 267 | 0.040 |
Why?
|
Pharmacists | 1 | 2021 | 261 | 0.040 |
Why?
|
Hirudins | 1 | 2019 | 179 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2007 | 2194 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11206 | 0.040 |
Why?
|
Glucose | 2 | 2022 | 4355 | 0.040 |
Why?
|
Apolipoproteins | 1 | 2020 | 328 | 0.040 |
Why?
|
Professional Role | 1 | 2021 | 316 | 0.040 |
Why?
|
Metagenomics | 1 | 2022 | 476 | 0.040 |
Why?
|
Vital Capacity | 1 | 2021 | 984 | 0.040 |
Why?
|
Radial Artery | 1 | 2019 | 188 | 0.040 |
Why?
|
Telephone | 1 | 2021 | 630 | 0.040 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7449 | 0.040 |
Why?
|
Cachexia | 1 | 2019 | 202 | 0.040 |
Why?
|
Stereoisomerism | 1 | 2019 | 612 | 0.040 |
Why?
|
Dietary Fiber | 1 | 2022 | 767 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2014 | 18390 | 0.040 |
Why?
|
Radiometry | 1 | 2023 | 816 | 0.040 |
Why?
|
HIV Seronegativity | 2 | 2009 | 211 | 0.040 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2017 | 104 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2020 | 1007 | 0.040 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2017 | 317 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2023 | 12813 | 0.040 |
Why?
|
Torsion, Mechanical | 1 | 2017 | 15 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1643 | 0.040 |
Why?
|
Monitoring, Ambulatory | 1 | 2020 | 357 | 0.040 |
Why?
|
Biometry | 1 | 2020 | 565 | 0.040 |
Why?
|
Supine Position | 1 | 2017 | 208 | 0.030 |
Why?
|
Pneumococcal Vaccines | 1 | 2021 | 414 | 0.030 |
Why?
|
Intermittent Claudication | 1 | 2019 | 305 | 0.030 |
Why?
|
Antithrombins | 1 | 2019 | 294 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2020 | 1133 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2019 | 527 | 0.030 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2019 | 578 | 0.030 |
Why?
|
Horses | 1 | 2017 | 296 | 0.030 |
Why?
|
Neuroblastoma | 1 | 2005 | 1265 | 0.030 |
Why?
|
Vero Cells | 1 | 2017 | 486 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 650 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2021 | 730 | 0.030 |
Why?
|
Xanthines | 1 | 2016 | 120 | 0.030 |
Why?
|
Ribonucleosides | 1 | 2016 | 79 | 0.030 |
Why?
|
Healthcare Disparities | 2 | 2023 | 3412 | 0.030 |
Why?
|
Acute Disease | 3 | 2017 | 7245 | 0.030 |
Why?
|
Pulse | 1 | 2016 | 218 | 0.030 |
Why?
|
Immune System | 1 | 2021 | 801 | 0.030 |
Why?
|
Receptor, erbB-2 | 2 | 2020 | 2586 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2020 | 682 | 0.030 |
Why?
|
Kidney | 1 | 2011 | 7064 | 0.030 |
Why?
|
Attitude to Health | 1 | 2005 | 2030 | 0.030 |
Why?
|
Japan | 1 | 2020 | 1418 | 0.030 |
Why?
|
Lipoprotein(a) | 1 | 2020 | 488 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2021 | 1820 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1235 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 2331 | 0.030 |
Why?
|
Models, Cardiovascular | 2 | 2012 | 986 | 0.030 |
Why?
|
Neutralization Tests | 1 | 2017 | 737 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2016 | 368 | 0.030 |
Why?
|
Drug Utilization | 1 | 2021 | 1192 | 0.030 |
Why?
|
Angina Pectoris | 1 | 2019 | 960 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2019 | 500 | 0.030 |
Why?
|
Models, Biological | 2 | 2008 | 9505 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2020 | 1145 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2019 | 893 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1196 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2017 | 478 | 0.030 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2015 | 139 | 0.030 |
Why?
|
Patient Positioning | 1 | 2017 | 332 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2021 | 941 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2022 | 941 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2020 | 1026 | 0.030 |
Why?
|
Bone Marrow | 1 | 2005 | 2929 | 0.030 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1195 | 0.030 |
Why?
|
Sweden | 1 | 2017 | 1382 | 0.030 |
Why?
|
Administration, Oral | 1 | 2022 | 4040 | 0.030 |
Why?
|
Compliance | 1 | 2014 | 100 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2022 | 1359 | 0.030 |
Why?
|
Residence Characteristics | 2 | 2015 | 2119 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1371 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6856 | 0.030 |
Why?
|
Warfarin | 1 | 2022 | 1493 | 0.030 |
Why?
|
Renin | 1 | 2016 | 642 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2674 | 0.030 |
Why?
|
Triage | 1 | 2021 | 997 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2339 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2079 | 0.030 |
Why?
|
Cholesterol Esters | 1 | 2013 | 72 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1370 | 0.030 |
Why?
|
Antimalarials | 1 | 2020 | 910 | 0.030 |
Why?
|
Influenza Vaccines | 1 | 2021 | 781 | 0.030 |
Why?
|
Rectus Abdominis | 1 | 2013 | 103 | 0.030 |
Why?
|
Pectoralis Muscles | 1 | 2013 | 86 | 0.030 |
Why?
|
Brain | 2 | 2021 | 27439 | 0.030 |
Why?
|
HIV Seropositivity | 2 | 2009 | 963 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2564 | 0.030 |
Why?
|
Gated Blood-Pool Imaging | 1 | 2012 | 44 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2854 | 0.030 |
Why?
|
Galectins | 1 | 2016 | 296 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2017 | 1998 | 0.030 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2013 | 127 | 0.030 |
Why?
|
Transaminases | 1 | 2013 | 199 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1421 | 0.030 |
Why?
|
Independent Living | 1 | 2016 | 580 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2013 | 290 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4861 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2082 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2021 | 2450 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2023 | 4774 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2021 | 1677 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2013 | 321 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2003 | 2102 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2243 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 2 | 2011 | 1434 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2013 | 410 | 0.020 |
Why?
|
Computational Biology | 1 | 2024 | 3549 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2785 | 0.020 |
Why?
|
Respiratory Sounds | 1 | 2016 | 702 | 0.020 |
Why?
|
Aldosterone | 1 | 2016 | 874 | 0.020 |
Why?
|
Amino Acids, Aromatic | 1 | 2011 | 36 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2021 | 2239 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2020 | 2433 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2005 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.020 |
Why?
|
Thorax | 1 | 2013 | 559 | 0.020 |
Why?
|
Testosterone | 2 | 2011 | 2493 | 0.020 |
Why?
|
Blood Proteins | 1 | 2016 | 1183 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 66 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3813 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6320 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1640 | 0.020 |
Why?
|
Sampling Studies | 1 | 2011 | 617 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6527 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2022 | 3697 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2018 | 1389 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2730 | 0.020 |
Why?
|
Iron Overload | 1 | 2012 | 241 | 0.020 |
Why?
|
Fasting | 1 | 2016 | 1608 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5793 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15879 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2994 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2723 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2013 | 1103 | 0.020 |
Why?
|
Niacinamide | 1 | 2011 | 419 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3615 | 0.020 |
Why?
|
Injections, Jet | 1 | 2008 | 8 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2013 | 583 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2013 | 1604 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1742 | 0.020 |
Why?
|
Anus Diseases | 1 | 2009 | 54 | 0.020 |
Why?
|
Contraceptives, Oral | 1 | 2011 | 562 | 0.020 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2011 | 554 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2015 | 1487 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4403 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2513 | 0.020 |
Why?
|
Organ Specificity | 1 | 2013 | 1974 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4213 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2126 | 0.020 |
Why?
|
San Francisco | 1 | 2008 | 166 | 0.020 |
Why?
|
Hyperinsulinism | 1 | 2011 | 401 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2011 | 532 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4247 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2013 | 1868 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10784 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2018 | 2705 | 0.020 |
Why?
|
Cell Line | 2 | 2013 | 15610 | 0.020 |
Why?
|
Health Behavior | 1 | 2019 | 2649 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4613 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 2768 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1795 | 0.020 |
Why?
|
Premenopause | 1 | 2011 | 1039 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8372 | 0.020 |
Why?
|
Creatine Kinase | 1 | 2009 | 685 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2693 | 0.020 |
Why?
|
Gadolinium | 1 | 2012 | 965 | 0.020 |
Why?
|
Biopsy | 2 | 2009 | 6816 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1889 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3790 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7440 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1379 | 0.020 |
Why?
|
Sarcoidosis | 1 | 2012 | 539 | 0.020 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 900 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4728 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2018 | 2078 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2003 | 9261 | 0.020 |
Why?
|
Canada | 1 | 2011 | 2143 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9359 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11249 | 0.020 |
Why?
|
Vena Cava, Inferior | 1 | 2008 | 463 | 0.020 |
Why?
|
Cytodiagnosis | 1 | 2009 | 452 | 0.020 |
Why?
|
Edema | 1 | 2009 | 766 | 0.010 |
Why?
|
NF-kappa B | 1 | 2013 | 2491 | 0.010 |
Why?
|
Causality | 1 | 2011 | 1255 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2013 | 1974 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3858 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2012 | 2126 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6880 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4294 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4816 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2742 | 0.010 |
Why?
|
Androgens | 1 | 2011 | 1285 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6537 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4022 | 0.010 |
Why?
|
Models, Molecular | 1 | 2013 | 5441 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2009 | 711 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 13045 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3771 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5443 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2819 | 0.010 |
Why?
|
Connecticut | 1 | 2003 | 365 | 0.010 |
Why?
|
Homeostasis | 1 | 2013 | 3351 | 0.010 |
Why?
|
Postmenopause | 1 | 2011 | 2519 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 3111 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5803 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6979 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 2009 | 988 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6353 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1894 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2003 | 642 | 0.010 |
Why?
|
Fatigue | 1 | 2009 | 1556 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2011 | 1498 | 0.010 |
Why?
|
Patient Readmission | 1 | 2016 | 3308 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7467 | 0.010 |
Why?
|
Image Enhancement | 1 | 2012 | 2895 | 0.010 |
Why?
|
Dyspnea | 1 | 2009 | 1352 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2014 | 12450 | 0.010 |
Why?
|
Neutropenia | 1 | 2005 | 892 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2013 | 4948 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6087 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2008 | 1317 | 0.010 |
Why?
|
Probability | 1 | 2003 | 2483 | 0.010 |
Why?
|
Creatinine | 1 | 2003 | 1915 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2005 | 1183 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2362 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8051 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2003 | 1277 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 9623 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11928 | 0.010 |
Why?
|
Anemia | 1 | 2005 | 1521 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2003 | 6242 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8510 | 0.010 |
Why?
|